These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. How proteins come together in the plasma membrane and function in macromolecular assemblies: focus on receptor mosaics. Agnati LF; Guidolin D; Genedani S; Ferré S; Bigiani A; Woods AS; Fuxe K J Mol Neurosci; 2005; 26(2-3):133-54. PubMed ID: 16012187 [TBL] [Abstract][Full Text] [Related]
27. Cardiovascular effects of intrathecal administration of agents active at 5-hydroxytryptamine1-receptors in the rat: modulation by substance P and a substance P antagonist. Gradin K; Persson B J Neural Transm Gen Sect; 1993; 93(3):225-34. PubMed ID: 7692886 [TBL] [Abstract][Full Text] [Related]
28. Receptor-receptor interactions as an integrative mechanism in nerve cells. Zoli M; Agnati LF; Hedlund PB; Li XM; Ferré S; Fuxe K Mol Neurobiol; 1993; 7(3-4):293-334. PubMed ID: 7514001 [TBL] [Abstract][Full Text] [Related]
29. Neuropeptide Y enhances the inhibitory effects of clonidine on 3H-noradrenaline release in synaptosomes isolated from the medulla oblongata of the male rat. Martire M; Fuxe K; Pistritto G; Preziosi P; Agnati LF J Neural Transm; 1986; 67(1-2):113-24. PubMed ID: 3783148 [TBL] [Abstract][Full Text] [Related]
30. The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats. Stoessl AJ; Dourish CT; Iversen SD Br J Pharmacol; 1988 Jun; 94(2):285-7. PubMed ID: 2456111 [TBL] [Abstract][Full Text] [Related]
31. Effects of acute and chronic treatment with imipramine on 5-hydroxytryptamine nerve cell groups and on bulbospinal 5-hydroxytryptamine/substance P/thyrotropin releasing hormone immunoreactive neurons in the rat. A morphometric and microdensitometric analysis. Kitayama I; Janson AM; Fuxe K; Agnati LF; Cintra A; Ogren SO; Härfstrand A; Eneroth P; Tsutsumi T; Jonsson G J Neural Transm; 1987; 70(3-4):251-85. PubMed ID: 2445912 [TBL] [Abstract][Full Text] [Related]
32. Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment. Iverfeldt K; Peterson LL; Brodin E; Ogren SO; Bartfai T Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):1-6. PubMed ID: 2426604 [TBL] [Abstract][Full Text] [Related]
33. Cardiovascular effects of intrathecal administration of substance P in the rat: interactions with serotonergic mechanisms. Gradin K; Persson B J Neural Transm Gen Sect; 1992; 87(3):199-213. PubMed ID: 1374613 [TBL] [Abstract][Full Text] [Related]
34. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding. Pranzatelli MR; Murthy JN; Pluchino RS J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361 [TBL] [Abstract][Full Text] [Related]
35. The distribution of serotonergic 5-HT1A and non-5-HT1A recognition sites along the dorso-ventral axis of the rat hippocampus. Kiedrowski L Pol J Pharmacol Pharm; 1991; 43(2):103-13. PubMed ID: 1946036 [TBL] [Abstract][Full Text] [Related]
36. Multiple 3H-5-hydroxytryptamine binding sites in rat brain. Nelson DL; Pedigo NW; Yamamura HI J Physiol (Paris); 1981; 77(2-3):369-72. PubMed ID: 7288652 [TBL] [Abstract][Full Text] [Related]
37. On the functional role of coexistence of 5-HT and substance P in bulbospinal 5-HT neurons. Substance P reduces affinity and increases density of 3H-5-HT binding sites. Agnati LF; Fuxe K; Benfenati F; Zini I; Hökfelt T Acta Physiol Scand; 1983 Feb; 117(2):299-301. PubMed ID: 6191525 [No Abstract] [Full Text] [Related]
38. Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides. Fuxe K; Agnati LF; Benfenati F; Celani M; Zini I; Zoli M; Mutt V J Neural Transm Suppl; 1983; 18():165-79. PubMed ID: 6192208 [TBL] [Abstract][Full Text] [Related]